Medicine passport

MADOPAR RETARD 100 mg levodopa; 25 mg benserazida

The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.

Active substance
Levodopa + benserazida
Strength
100 mg levodopa; 25 mg benserazida
Form
cápsula dura de liberación prolongada
ATC code
N04BA02
Registered in
Spain · Roche Farma S.A.
Prescription
Prescription only
Nº Registro
62162

Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30

Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.

Listed in other countries

Canada 1 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
PROLOPA CAP100 mg + 25 mg · capsulePrescription onlyHoffmann-La Roche Limited00386464

Source: Drug Product Database (Health Canada) · 2026-09-30 · Contains information licensed under the Open Government Licence – Canada.

Same active substance, but no match for this strength and form

Countries covered: United States, Bulgaria, European Union, Spain, France, Netherlands, Canada, Switzerland. A country missing from the list may still sell this medicine: Mediclarum reads only these registers.

Register data as of 2026-09-30. Mediclarum stores nothing about you for this page. https://www.mediclarum.com/es/en/medicines/madopar-retard-100-mg-levodopa-25-mg-benserazida-capsula-dura-de-liberac